Neimeth International Pharmaceuticals plc announced earnings results for the year ended September 30, 2013. For the period, the company reported a turnover of NGN 2,017 billion as against NGN 1,519 billion (adjusted to 12 months) in 2012, showing a growth indices of 33%. With top line revenue of NGN 2,017 billion the company showed an impressive gross margin of NGN 642 million, a growth of 21% over 2012's NGN 529 million (adjusted to 12 months) Profit before tax showed a significant growth of 451%, NGN 183 million, against NGN 52 million in 2012.